Simplex Trading
CGON icon

Simplex Trading’s CG Oncology CGON Stock Holding History

Simplex Trading’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$920K Sell
13,600
-40,100
-75% -$2.27M ﹤0.01% 2590
2025
Q4 		$2.23M Buy
53,700
+46,000
+597% +$1.9M ﹤0.01% 1889
2025
Q3 		$310K Sell
7,700
-3,300
-30% -$95.9K ﹤0.01% 4404
2025
Q2 		$286K Buy
11,000
+2,800
+34% +$67.5K ﹤0.01% 4123
2025
Q1 		$200K Buy
8,200
+600
+8% +$16.9K ﹤0.01% 4327
2024
Q4 		$217K Buy
7,600
+2,200
+41% +$75.3K ﹤0.01% 4428
2024
Q3 		$203K Buy
+5,400
New +$189K ﹤0.01% 4499
2024
Q2 		– Sell
-1,100
Closed -$48K – 8875
2024
Q1 		$48K Buy
+1,100
New +$44.9K ﹤0.01% 6292

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Simplex Trading's CGON Position: Q3 2024 in Review

Simplex Trading sold out of CG Oncology (CGON) in Q3 2024, closing a stake of 264 shares — an estimated $9.26K sold.

Simplex Trading first reported a position in CGON in Q2 2024 and held it in 1 quarter. The position peaked at $8K in Q2 2024. 121 funds tracked by Wall St. Rank hold CGON as of Q3 2024.

  • Simplex Trading reported no remaining CG Oncology position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 264 CG Oncology shares in Q3 2024, an estimated $9.26K.
  • Simplex Trading first reported a position in CG Oncology in Q2 2024 and held it in 1 quarter.
  • Simplex Trading's CG Oncology position peaked at $8K in Q2 2024.
  • 121 funds tracked by Wall St. Rank held CG Oncology as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.